Core Outcome Set for Actinic Keratosis Clinical Trials

Psoriasis

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials

JAMA Dermatol.

Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW

doi: 10.1001/jamadermatol.

Long-term clinical outcomes of imiquimod 5% cream versus diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials

J Eur Acad Dermatol Venereol.

Gollnick H, Dirschka T, Ostendorf R, Kerl H, Kunstfeld R

doi: 10.1111/jdv.15868.

Atopic Dermatitis

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

Br J Dermatol

Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N

doi: 10.1111/bjd.19751

Osteoarthritis

Efficacy of a Combination of Conservative Therapies vs an Education Comparator on Clinical Outcomes in Thumb Base Osteoarthritis: A Randomized Clinical Trial

JAMA Intern Med

Deveza LA, Robbins SR, Duong V, Bennell KL, Vicenzino B, Hodges PW, Wajon A, Jongs R, Riordan EA, Fu K, Oo WM, O'Connell RL, Eyles JP, Hunter DJ

doi: 10.1001/jamainternmed.2020.7101

Effect of Expedited Microneedle-Assisted Photodynamic Therapy for Field Treatment of Actinic Keratoses: A Randomized Clinical Trial

JAMA Dermatol.

Petukhova TA, Hassoun LA, Foolad N, Barath M, Sivamani RK

doi: 10.1001/

Vitiligo

Standardizing serial photography for assessing and monitoring vitiligo: a core set of international recommendations for essential clinical and technical specifications

J Am Acad Dermatol.

van Geel N, Hamzavi I, Kohli I, Wolkerstorfer A, Lim HW, Bae JM, Lui H, Harris JE, Pandya AG, Guan STT, Abdallah M, Esmat S, Seneschal J, Speeckaert R, Grine L, Kang HY, Raboobee N, Xiang LF, Bekkenk M, Picardo M, Taieb A

doi: 10.1016/j.jaad.2019.10.055.

Further Publications Rheumatology

The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2

Semin Arthritis Rheum

Maxwell LJ, Beaton DE, Boers M, D'Agostino MA, Conaghan PG, Grosskleg S, Shea BJ, Bingham Iii CO, Boonen A, Christensen R, Choy E, Doria AS, Hill CL, Hofstetter C, Kroon FP, Leung YY, Mackie S, Meara A, Touma Z, Tugwell P, Wells GA

doi: 10.1016/j.semarthrit.2021.08.011

Psoriatic Arthritis

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study

Semin Arthritis Rheum.

Coates LC, Nash P, Kvien TK, Gossec L, Mease PJ, Rasouliyan L, Pricop L, Jugl SM, Gandhi KK, Gaillez C, Smolen JS

doi: 10.1016/j.semarthrit.2020.03.015.

Rheumatoid Arthritis

Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis

Rheumatology (Oxford).

Rubbert-Roth A, Aletaha D, Devenport J, Sidiropoulos PN, Luder Y, Edwardes MD, Jacobs JWG

doi: 10.1093/rheumatology/keaa259.

Related content